KLK3 and cancer: Risk calculators have been developed, they combine age, PSA, DRE, trans-rectal ultrasound (TRUS), PSA density (PSAD), prostate volume, and more recent MRIs to better differentiate indolent cancers from clinically significant ones, but they can be improved [16,17].